Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system

Overview of attention for article published in Science Translational Medicine, July 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 40 news outlets
blogs: 4 blogs

twitter: 55 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 7 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 65 X posts from 55 X users, with an upper bound of 183,027 followers.

Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science Translational Medicine https://t.co/4hBCnmfrHx https://t.co/T94F5l5dd3

20 Aug 2024

Reply Repost Favourite

The original paper -> https://t.co/KqtCk6NnI6

05 Aug 2024

Reply Repost Favourite

Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science Translational Medicine https://t.co/1YVEW8lC4f

03 Aug 2024

Reply Repost Favourite

RT @DanielJDrucker: Advances in expanding human beta cell mass #diabetes Harmine + Exendin-4 promote altered β cell proliferation, function…

30 Jul 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 61 additional X posts.